glp 1 receptor agonist moa GLP1 Agonists—Effects beyond Obesity and Diabetes Emerging Frontiers in GLP-1 Therapeutics:

Summary GLP-1R agonists appear to perform favorably compared with other approved pharmacological agents for pediatric obesity

Different Classes of Beta-Blockers and Specific Drugs Beta-blockers that are used clinically can be divided into two classes: 1) non-selective blockers (block both 1 and 2 receptors) , or 2) relatively selective 1 blockers ("cardioselective" beta-blockers)

W.LadensteinR.SchfferJ.GallayO.HuberR

This balance between IGF-1 and growth hormone is critical to human growth and development

Zhang et al., 2022a

For instance, the activation of sterol regulatory element-binding proteins (SREBPs) drives the upregulation of key metabolic enzymes (e.g., ACLY, FASN, and HMGCR) [8,9,10], enabling tumor cells to coopt de novo lipogenesis and cholesterol synthesis, which secures the supply of structural building blocks required to sustain tumor expansion